Erlocip 150mg Tablet contains Erlotinib, a potent oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). This medication is primarily indicated for the treatment of advanced non-small cell lung cancer (NSCLC) and pancreatic cancer. By blocking EGFR signaling, Erlotinib helps to impede tumor growth and spread, making it a crucial component of targeted cancer therapy.
Key Features:
- Contains Erlotinib, a leading oral targeted therapy
- Used for treating non-small cell lung cancer (NSCLC) and pancreatic cancer
- Inhibits the action of EGFR to slow down cancer cell growth
- Convenient oral administration for easy patient compliance
- Often used as part of a comprehensive cancer treatment regimen
Reviews
There are no reviews yet